Suppr超能文献

参与结直肠癌肝转移发生和发展的受体酪氨酸激酶的蛋白质组定量分析。

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis.

作者信息

Vasilogianni Areti-Maria, Al-Majdoub Zubida M, Achour Brahim, Peters Sheila Annie, Rostami-Hodjegan Amin, Barber Jill

机构信息

Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, United Kingdom.

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States.

出版信息

Front Oncol. 2023 Feb 20;13:1010563. doi: 10.3389/fonc.2023.1010563. eCollection 2023.

Abstract

INTRODUCTION

Alterations in expression and activity of human receptor tyrosine kinases (RTKs) are associated with cancer progression and in response to therapeutic intervention.

METHODS

Thus, protein abundance of 21 RTKs was assessed in 15 healthy and 18 cancerous liver samples [2 primary and 16 colorectal cancer liver metastasis (CRLM)] matched with non-tumorous (histologically normal) tissue, by a validated QconCAT-based targeted proteomic approach.

RESULTS

It was demonstrated, for the first time, that the abundance of EGFR, INSR, VGFR3 and AXL, is lower in tumours relative to livers from healthy individuals whilst the opposite is true for IGF1R. EPHA2 was upregulated in tumour compared with histologically normal tissue surrounding it. PGFRB levels were higher in tumours relative to both histologically normal tissue surrounding tumour and tissues taken from healthy individuals. The abundances of VGFR1/2, PGFRA, KIT, CSF1R, FLT3, FGFR1/3, ERBB2, NTRK2, TIE2, RET, and MET were, however, comparable in all samples. Statistically significant, but moderate correlations were observed (Rs > 0.50, p < 0.05) for EGFR with INSR and KIT. FGFR2 correlated with PGFRA and VGFR1 with NTRK2 in healthy livers. In non-tumorous (histologically normal) tissues from cancer patients, there were correlations between TIE2 and FGFR1, EPHA2 and VGFR3, FGFR3 and PGFRA (p < 0.05). EGFR correlated with INSR, ERBB2, KIT and EGFR, and KIT with AXL and FGFR2. In tumours, CSF1R correlated with AXL, EPHA2 with PGFRA, and NTRK2 with PGFRB and AXL. Sex, liver lobe and body mass index of donors had no impact on the abundance of RTKs, although donor age showed some correlations. RET was the most abundant of these kinases in non-tumorous tissues (35%), while PGFRB was the most abundant RTK in tumours (47%). Several correlations were also observed between the abundance of RTKs and proteins relevant to drug pharmacokinetics (enzymes and transporters).

DISCUSSION

DiscussionThis study quantified perturbation to the abundance of several RTKs in cancer and the value generated in this study can be used as input to systems biology models defining liver cancer metastases and biomarkers of its progression.

摘要

引言

人类受体酪氨酸激酶(RTK)的表达和活性改变与癌症进展及对治疗干预的反应相关。

方法

因此,采用经过验证的基于QconCAT的靶向蛋白质组学方法,在15份健康肝脏样本和18份癌性肝脏样本(2份原发性肝癌和16份结直肠癌肝转移瘤)及其配对的非肿瘤(组织学正常)组织中评估了21种RTK的蛋白质丰度。

结果

首次证明,相对于健康个体的肝脏,肿瘤中表皮生长因子受体(EGFR)、胰岛素受体(INSR)、血管内皮生长因子受体3(VGFR3)和AXL的丰度较低,而胰岛素样生长因子1受体(IGF1R)则相反。与肿瘤周围组织学正常的组织相比,EPHA2在肿瘤中上调。相对于肿瘤周围组织学正常的组织和取自健康个体的组织,血小板衍生生长因子受体B(PGFRB)在肿瘤中的水平更高。然而,在所有样本中,血管内皮生长因子受体1/2(VGFR1/2)、血小板衍生生长因子受体α(PGFRA)、干细胞因子受体(KIT)、集落刺激因子1受体(CSF1R)、FMS样酪氨酸激酶3(FLT3)、成纤维细胞生长因子受体1/3(FGFR1/3)、人表皮生长因子受体2(ERBB2)、神经营养酪氨酸激酶受体2(NTRK2)、血管生成素受体(TIE2)、转染重排(RET)和肝细胞生长因子受体(MET)的丰度相当。观察到EGFR与INSR和KIT存在显著但中等程度的相关性(Rs>0.50,p<(0.05))。在健康肝脏中,FGFR2与PGFRA相关,VGFR1与NTRK2相关。在癌症患者的非肿瘤(组织学正常)组织中,TIE2与FGFR1、EPHA2与VGFR3、FGFR3与PGFRA之间存在相关性(p<0.05)。EGFR与INSR、ERBB2、KIT相关,KIT与AXL和FGFR2相关。在肿瘤中,CSF1R与AXL相关,EPHA2与PGFRA相关,NTRK2与PGFRB和AXL相关。供体的性别、肝叶和体重指数对RTK的丰度没有影响,尽管供体年龄显示出一些相关性。RET是这些激酶在非肿瘤组织中最丰富的(约35%),而PGFRB是肿瘤中最丰富的RTK(约47%)。还观察到RTK丰度与药物药代动力学相关蛋白(酶和转运体)之间存在若干相关性。

讨论

本研究量化了癌症中几种RTK丰度的扰动,本研究产生的价值可作为定义肝癌转移及其进展生物标志物的系统生物学模型的输入。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/9986493/3a4d19197dba/fonc-13-1010563-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验